Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Liabilities and Shareholders Equity: 2010-2024

Historic Liabilities and Shareholders Equity for Nutex Health (NUTX) over the last 15 years, with FY2024 value amounting to $655.3 million.

  • Nutex Health's Liabilities and Shareholders Equity rose 11996.42% to $964.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 billion, marking a year-over-year increase of 9374.42%. This contributed to the annual value of $655.3 million for FY2024, which is 6455.18% up from last year.
  • According to the latest figures from FY2024, Nutex Health's Liabilities and Shareholders Equity is $655.3 million, which was up 6455.18% from $398.2 million recorded in FY2023.
  • Nutex Health's Liabilities and Shareholders Equity's 5-year high stood at $655.3 million during FY2024, with a 5-year trough of $169857.0 in FY2020.
  • In the last 5 years, Nutex Health's Liabilities and Shareholders Equity had a median value of $398.2 million in 2023 and averaged $376.0 million.
  • In the last 5 years, Nutex Health's Liabilities and Shareholders Equity tumbled by 9746.2% in 2020 and then skyrocketed by 23224252.52% in 2021.
  • Annual analysis of 5 years shows Nutex Health's Liabilities and Shareholders Equity stood at $169857.0 in 2020, then surged by 232242.53% to $394.7 million in 2021, then rose by 9.4% to $431.8 million in 2022, then decreased by 7.76% to $398.2 million in 2023, then skyrocketed by 64.55% to $655.3 million in 2024.
  • Its Liabilities and Shareholders Equity was $655.3 million in FY2024, compared to $398.2 million in FY2023 and $431.8 million in FY2022.